Cibus will present at the Sidoti Micro Cap Conference on January 23, detailing its gene editing technologies for agriculture.
Quiver AI Summary
Cibus, Inc., an agricultural biotechnology company focused on gene editing technologies for developing specific plant traits, announced that its Co-Founder and CEO, Rory Riggs, along with Co-Founder and COO, Peter Beetham, will present at the Sidoti Micro Cap Conference on January 23, 2025. Cibus specializes in addressing agricultural productivity and sustainability challenges, particularly those caused by diseases and pests, which the UN estimates to cost the global economy around $300 billion annually. Unlike traditional seed companies, Cibus operates as a technology company that develops and licenses traits to seed companies for royalties on seed sales. The company is advancing a range of productivity traits for major crops, with some traits already in commercial development with leading seed firms in North America and Latin America.
Potential Positives
- Announcement of a presentation at the Sidoti Micro Cap Conference highlights Cibus' leadership and innovation in agricultural biotechnology, potentially increasing visibility among investors.
- Cibus’ proprietary gene editing technologies position the company as a leader in addressing significant agricultural challenges, which could attract partnerships and collaborations.
- The company's pipeline of five productivity traits and their advancements in commercial development demonstrate strong growth potential and expertise in the market.
- Collaboration with leading seed companies for trait development signals confidence and value in Cibus’ technology, enhancing its reputation within the industry.
Potential Negatives
- The press release does not detail specific financial projections or outcomes from the company's pipeline, which may raise concerns about the company's future profitability and market impact.
- It lacks disclosure of any potential risks or challenges associated with the deployment of its gene editing technologies, which could leave investors uncertain about the viability of their investments.
- The announcement of presentations at a conference may suggest a need for more investor engagement, highlighting potential concerns regarding the company's current visibility and investor confidence.
FAQ
What is Cibus, Inc. known for?
Cibus, Inc. specializes in agricultural biotechnology, focusing on proprietary gene editing technologies to develop plant traits in seeds.
When is Cibus presenting at the Sidoti Micro Cap Conference?
Cibus will present at the Sidoti Micro Cap Conference on Thursday, January 23, 2025, at 1:45 p.m. ET.
How does Cibus support farmers?
Cibus addresses productivity and sustainability challenges for farmers by developing gene-edited traits for crops that combat diseases and pests.
What types of crops are Cibus' productivity traits focused on?
Cibus focuses on major global row crops such as canola, corn, rice, soybean, and wheat for its productivity traits.
What is Cibus' approach to gene editing?
Cibus utilizes high throughput gene editing technology to develop and commercialize plant traits more quickly and cost-effectively than conventional breeding.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$CBUS Insider Trading Activity
$CBUS insiders have traded $CBUS stock on the open market 35 times in the past 6 months. Of those trades, 0 have been purchases and 35 have been sales.
Here’s a breakdown of recent trading of $CBUS stock by insiders over the last 6 months:
- GERHARD PRANTE has made 0 purchases and 34 sales selling 40,250 shares for an estimated $147,786.
- CARLO BROOS (Interim CFO) sold 4,647 shares for an estimated $24,629
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CBUS Hedge Fund Activity
We have seen 35 institutional investors add shares of $CBUS stock to their portfolio, and 16 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC added 566,328 shares (+16.9%) to their portfolio in Q3 2024, for an estimated $1,846,229
- ARMISTICE CAPITAL, LLC removed 516,000 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $1,682,160
- MILLENNIUM MANAGEMENT LLC added 142,849 shares (+inf%) to their portfolio in Q3 2024, for an estimated $465,687
- STATE STREET CORP added 93,236 shares (+43.6%) to their portfolio in Q3 2024, for an estimated $303,949
- NORTHERN TRUST CORP added 89,521 shares (+179.9%) to their portfolio in Q3 2024, for an estimated $291,838
- BLACKROCK, INC. added 81,710 shares (+8.3%) to their portfolio in Q3 2024, for an estimated $266,374
- ALPINE GLOBAL MANAGEMENT, LLC added 74,458 shares (+507.3%) to their portfolio in Q3 2024, for an estimated $242,733
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
SAN DIEGO, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company”), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced that Rory Riggs, Co-Founder, Chief Executive Officer, and Chairman, and Peter Beetham, Co-Founder, President, and Chief Operating Officer, will host a presentation at the Sidoti Micro Cap Conference.
Presentation details
Date: Thursday, January 23, 2025
Time: 1:45 p.m. ET (10:45 a.m. PT)
Webcast link:
https://sidoti.zoom.us/webinar/register/WN_zgpeW_rJSbS6UDdU4sskZQ
About Cibus
Cibus is a leader in gene edited productivity traits that address critical productivity and sustainability challenges for farmers such as diseases and pests which the United Nations estimates cost the global economy approximately $300 billion annually. Cibus is not a seed company. It is a technology company that uses gene editing to develop and license traits to seed companies in exchange for royalties on seed sales. Cibus’ focus is productivity traits for farmers for the major global row crops with large acreage such as canola, corn, rice, soybean, and wheat. Cibus is a technology leader in high throughput gene editing technology that enables Cibus to develop and commercialize plant traits at a fraction of the time and cost of conventional breeding. Cibus has developed a pipeline of five productivity traits including important traits for Pod Shatter Reduction, Sclerotinia (disease) resistance, and weed management. Its initial traits for Pod Shatter Reduction and weed management are in commercial development with leading seed companies such as Nuseed Americas Inc. in Canola as well as Nutrien Ltd. and Interoc S.A. in Rice in the United States and Latin America. Its other pipeline traits including Sclerotinia resistance are in advanced greenhouse and field trials stages.
CIBUS CONTACTS:
INVESTOR RELATIONS
Karen Troeber
[email protected]
858-450-2636
Jeff Sonnek – ICR
[email protected]
MEDIA RELATIONS
Colin Sanford
[email protected]
203-918-4347